Search - tctmd.com

Presenter: Hideki Kitahara, Teruyoshi Kume, Katsuhisa Waseda, Kenji Sakamoto, Ryotaro Yamada, Paul Yock, Ian T. Meredith, Martin B. Leon, Laura Mauri, Alan C. Yeung, Peter J. Fitzgerald, Yasuhiro Honda

January 03, 2012

Presentation TCT 2012

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Presenter: Young-Guk Ko, Dong-Ho Shin, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Hyeon-Cheol Gwon, Taehoon Ahn, In-Ho Chae, Jung-Han Yoon, Hyo-Soo Kim, Yangsoo Jang

January 03, 2012

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

Advertisement

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

IN.PACT SFA: Benefits of DCB Persist at 2 Years

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

TCTMD’s Top 10 Most Popular News Stories From 2011

Relative Dose and Vascular Response After Resolute Zotarolimus-Eluting Stent Implantation: A Dosimetric 3D-Intravascular Ultrasound Study.

Neointimal Hyperplasia and Peristent Vascular Remodeling after Implantation of Everolimus-eluting Stent versus Sirolimus-eluting Stent. Intravascular Ultrasound Results from...

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content